AAAAAA
Results: 1-25/118
Authors:
KORFEL A
SCHEULEN ME
SCHMOLL HJ
GRUNDEL O
HARSTRICK A
KNOCHE M
FELS LM
SKORZEC M
BACH F
BAUMGART J
SASS G
SEEBER S
THIEL E
BERDEL WE
Citation: A. Korfel et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF TITANOCENE DICHLORIDE IN ADULTS WITH ADVANCED SOLID TUMORS, Clinical cancer research, 4(11), 1998, pp. 2701-2708
Authors:
SCHMOLL HJ
Citation: Hj. Schmoll, IS THERE A STANDARD ADJUVANT TREATMENT FOR COLON-CANCER - ARBITER, European journal of cancer, 34(11), 1998, pp. 1659-1663
PHASE-I PHARMACOLOGICAL STUDY OF INTRAARTERIALLY INFUSED FOTEMUSTINE FOR COLORECTAL LIVER METASTASES
Authors:
HARTMANN JT
SCHMOLL E
BOKEMEYER C
FETY R
LUCAS C
GIROUX B
SCHMOLL HJ
Citation: Jt. Hartmann et al., PHASE-I PHARMACOLOGICAL STUDY OF INTRAARTERIALLY INFUSED FOTEMUSTINE FOR COLORECTAL LIVER METASTASES, European journal of cancer, 34(1), 1998, pp. 87-91
Authors:
HARTMANN JT
NICHOLS CR
DROZ JP
HORWICH A
GERL A
FOSSA SD
BEYER J
PONT J
SCHMOLL HJ
BOKEMEYER C
Citation: Jt. Hartmann et al., EXTRAGONADAL GERM-CELL TUMORS (EGGCT) AND HEMATOLOGIC DISORDERS - INCIDENCE AND OUTCOME FROM AN INTERNATIONAL DATABASE, Annals of oncology, 9, 1998, pp. 268-268
Authors:
KOHNE CH
SCHOFFSKI P
WILKE H
KAUFER C
ANDREESEN R
OHL U
KLAASEN U
WESTERHAUSEN M
HIDDEMANN W
SCHOTT G
HARSTICK A
BADE J
HORSTER A
SCHUBERT U
HECKER H
DORKEN B
SCHMOLL HJ
Citation: Ch. Kohne et al., EFFECTIVE BIOMODULATION BY LEUCOVORIN OF HIGH-DOSE INFUSION FLUOROURACIL GIVEN AS A WEEKLY 24-HOUR INFUSION - RESULTS OF A RANDOMIZED TRIALIN PATIENTS WITH ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(2), 1998, pp. 418-426
Authors:
KOLLMANNSBERGER C
BOYER J
DROZ JP
HARSTRICK A
HARTMANN JT
BIRON P
FLECHON A
SCHOFFSKI P
KUCZYK M
SCHMOLL HJ
KANZ L
BOKEMEYER C
Citation: C. Kollmannsberger et al., SECONDARY LEUKEMIA FOLLOWING HIGH CUMULATIVE DOSES OF ETOPOSIDE IN PATIENTS TREATED FOR ADVANCED GERM-CELL TUMORS, Journal of clinical oncology, 16(10), 1998, pp. 3386-3391
Authors:
BOKEMEYER C
HARSTRICK A
BEYER J
METZNER B
RUTHER U
HARTMANN JT
HOLSTEIN K
DERIGS HG
DEWIT R
CASPER J
SCHOFFSKI P
KUHRER I
ILLIGER HJ
KEMPF B
REICHLE A
FOLLER A
HOSSFELD DK
FISCHER JT
BERDEL W
GERHARTZ H
KIRCHNER H
PFLUGER K
OSTERMANN H
KANZ L
SCHMOLL HJ
Citation: C. Bokemeyer et al., FIRST-LINE HIGH-DOSE CHEMOTHERAPY FOR POOR-RISK METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Onkologie, 21, 1998, pp. 23-25
Authors:
WILS J
SAHMOUD T
SOBRERO A
BLEIBERG H
AHMEDZAI S
BLAZEBY J
BLIJHAM G
CONROY T
CUNNINGHAM D
CURRAN D
DIAZRUBIO E
DUCREUX M
EVANS J
GLIMELIUS B
HUTCHINSON G
KERR D
KIEBERT G
KOHNE H
LABIANCA R
LANGENDIJK R
NITTI D
NORDLINGER B
ROUGIER P
SCHEITHAUER W
SCHMOLL HJ
VANCUTSEM E
WAGENER T
WILKE J
MARINUS A
THERASSE P
Citation: J. Wils et al., EVALUATION OF CLINICAL EFFICACY OF NEW MEDICAL TREATMENTS IN ADVANCEDCOLORECTAL-CANCER - RESULTS OF A WORKSHOP ORGANIZED BY THE EORTC GITCCG, Tumori, 84(3), 1998, pp. 335-347
Authors:
BEYER J
KRAMAR A
MANDANAS R
LINKESCH W
GREINIX A
DROZ JP
PICO JL
DIEHL A
BOKEMEYER C
SCHMOLL HJ
NICHOLS CR
EINHORN LH
SIEGERT W
Citation: J. Beyer et al., PROGNOSTIC FACTORS FOR HIGH-DOSE CHEMOTHERAPY (HDCT) AS SALVAGE TREATMENT IN GERM-CELL TUMORS (GCT), Bone marrow transplantation, 22, 1998, pp. 16-16
Authors:
DUNN TA
SCHMOLL HJ
RIE C
HARTMANN K
CASPER J
Citation: Ta. Dunn et al., PRODUCTION AND PRECLINICAL SIGNIFICANCE OF HEMATOPOIETIC PEPTIDE GROWTH-FACTORS (HPGF) IN HUMAN NONSEMINOMATOUS GERM-CELL TUMOR-CELL LINES, Journal of cancer research and clinical oncology, 124(8), 1998, pp. 435-443
Authors:
BOKEMEYER C
HARSTRICK A
BEYER J
METZNER B
RUTHER U
HARTMANN JT
HOLSTEIN K
DERIGS HG
DEWIT R
CASPER J
SCHOFFSKI P
KUHRER I
ILLIGER HJ
KEMPF B
REICHLE A
FOLLER A
HOSSFELD DK
FISCHER JT
BERDEL WE
GERHARTZ HH
KIRCHNER H
PFLUGER KH
OSTERMANN H
KANZ L
SCHMOLL HJ
Citation: C. Bokemeyer et al., THE USE OF DOSE-INTENSIFIED CHEMOTHERAPY IN THE TREATMENT OF METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS, Seminars in oncology, 25(2), 1998, pp. 24-32
Authors:
SCHMOLL HJ
BEYER J
Citation: Hj. Schmoll et J. Beyer, PROGNOSTIC FACTORS IN METASTATIC GERM-CELL TUMORS, Seminars in oncology, 25(2), 1998, pp. 174-185
Authors:
HARTMANN JT
KOHNE CH
SCHMOLL HJ
DAIKELER T
KANZ L
BOKEMEYER C
Citation: Jt. Hartmann et al., IS CONTINUOUS 24-HOUR INFUSION OF 5-FLUOROURACIL PLUS HIGH-DOSE FOLINIC ACID EFFECTIVE IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER - A PHASE-II STUDY, Oncology, 55(4), 1998, pp. 320-325
Authors:
FIBICH C
SCHOBER C
SCHMOLL HJ
Citation: C. Fibich et al., TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC-ANEMIAS WITH MYCOPHENOLATE-MOFFETIL (CELL-SEPT(R)), British Journal of Haematology, 102(1), 1998, pp. 39-39
Authors:
FIBICH C
SCHOBER C
KEGEL T
BULANKIN A
SCHADLICH B
KELLNER O
SCHMOLL HJ
Citation: C. Fibich et al., PACLITAXEL IN COMBINATION CHEMOTHERAPY FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR MULTICYCLE HIGH-DOSE CHEMOTHERAPY OF SOLID TUMORS, British Journal of Haematology, 102(1), 1998, pp. 73-73
Authors:
BOKEMEYER C
BERGER CC
HARTMANN JT
KOLLMANNSBERGER C
SCHMOLL HJ
KUCZYK MA
KANZ L
Citation: C. Bokemeyer et al., ANALYSIS OF RISK-FACTORS FOR CISPLATIN-INDUCED OTOTOXICITY IN PATIENTS WITH TESTICULAR CANCER, British Journal of Cancer, 77(8), 1998, pp. 1355-1362
Authors:
HARTMANN JT
SCHMOLL E
BOKEMEYER C
FETY R
LUCAS C
DAGAY L
SCHMOLL HJ
Citation: Jt. Hartmann et al., HEPATIC ARTERIAL INFUSION OF THE NITROSOUREA DERIVATE FOTEMUSTINE FORTHE TREATMENT OF LIVER METASTASES FROM COLORECTAL-CARCINOMA, Oncology Reports, 4(1), 1997, pp. 167-172
Authors:
SCHMOLL HJ
Citation: Hj. Schmoll, PROGNOSTIC FACTORS FOR ADVANCED SEMINOMA - A SOLID BASIS FOR CLINICAL-TRIALS, European journal of cancer, 33(9), 1997, pp. 1347-1350
Authors:
MALEK NP
CASPER J
LOOIJENGA LHJ
STROHMEYER T
SCHMOLL HJ
NORDHEIM A
JANKNECHT R
Citation: Np. Malek et al., QUANTIFICATION OF ADDITIONAL SHORT ARMS OF CHROMOSOME-12 IN GERM-CELLTUMORS USING THE POLYMERASE CHAIN-REACTION, European journal of cancer, 33(9), 1997, pp. 1488-1494
Authors:
SCHMOLL HJ
QUIETZSCH D
BORNER P
KETTNER E
MENNIGEN R
ZINGREBE M
PREISS J
Citation: Hj. Schmoll et al., SAFETY OF ADJUVANT MAB 17-1A IN COLORECTAL-CANCER (CRC), European journal of cancer, 33, 1997, pp. 750-750
Authors:
HARTMANN JT
KOHNE CH
SCHMOLL HJ
KOLLMANNSBERGER C
KANZ L
BOKEMEYER C
Citation: Jt. Hartmann et al., PHASE-II STUDY OF 24 HOURS-INFUSION OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER (CRC), European journal of cancer, 33, 1997, pp. 759-759
Authors:
BECKER A
BUCHELE T
SANDNER A
WEIGEL C
SCHOBER C
SCHMOLL HJ
Citation: A. Becker et al., PHASE I-II STUDY OF SIMULTANEOUS RADIOTHERAPY AND PACLITAXEL (TAXOL) IN A TWICE A WEEK (TIW) SCHEDULE FOR RECURRENT SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK (SCCHN), European journal of cancer, 33, 1997, pp. 872-872
Authors:
HARTMANN JT
CANDELARIA M
JACKH G
SCHMOLL HJ
HARSTRICK A
KANZ L
BOKEMEYER C
Citation: Jt. Hartmann et al., CONTINUOUS 120 HOURS-INFUSION OF MITOMYCIN-C (MMC) AS SALVAGE TREATMENT IN PROGRESSIVE OR RAPIDLY RECURRENT GASTRIC-CANCER, European journal of cancer, 33, 1997, pp. 1257-1257
Authors:
HARTMANN JT
CANDELARIA M
KUCZYK MA
SCHMOLL HJ
BOKEMEYER C
Citation: Jt. Hartmann et al., COMPARISON OF HISTOLOGICAL RESULTS FROM THE RESECTION OF RESIDUAL MASSES AT DIFFERENT SITES AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS, European journal of cancer, 33(6), 1997, pp. 843-847
Authors:
KOHNE CH
HARSTRICK A
HIDDEMANN W
SCHOFFSKI P
WILKE H
BOKEMEYER C
DORKEN B
SCHMOLL HJ
Citation: Ch. Kohne et al., MODULATION OF 5-FLUOROURACIL WITH METHOTREXATE AND LOW-DOSE N-(PHOSPHONACETYL)-1-ASPARTATE IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - RESULTS OF A PHASE-II STUDY, European journal of cancer, 33(11), 1997, pp. 1896-1899